Ara
Toplam kayıt 8, listelenen: 1-8
The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol
(Turkish Soc Cardiology, 2015)
Objective: Catestatin has several cardiovascular actions, in addition to diminished sympatho-adrenal flow. Decreased plasma catestatin levels may reflect a predisposition for the development of hypertension and metabolic ...
Elevated serum Osteoprotegerin levels predict in-hospital mace in patients with stemi
(Elsevier Ireland Ltd, 2013)
The amaç nın-nin bizim ders çalışma oldu -e incelemek olup olmadığı osteoprotegerin (OPG) dır-dir ilişkili -e hastanede majörters kalp Etkinlikler (TOPUZ) ve reperfüzyon parametreleri içinde hastalar ile ST yükseklik ...
Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study
(2013)
Amaç: Koroner yavaş akım (KYA) epikardiyal koroner arterlerin obstrüktif hastalık olmaksızın yavaş dolması ile karakterize bir durumdur. CD40/ CD40 ligandı (CD40L) sistemi artmış enflamasyon ve protrombotik yatkınlık ...
Plasma catestatin concentration is independently correlated with high-density lipoprotein cholesterol levels in untreated hypertensive patients
(Elsevier Science Inc, 2013)
Purpose
Catestatin (CST), a novel peptide derived from Chromogranin A, has diverse cardiovascular actions in addition to diminished sympathoadrenal flow. We intended to investigate metabolic and vascular associations of CST.
Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction
(Elsevier, 2012)
The aim of our study was to investigate whether osteoprotegerin (OPG) is related to in-hospital major adverse cardiac events (MACE) and reperfusion parameters in patients with ST elevation myocardial infarction (STEMI). ...
Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study
(2013)
Amaç: YKL-40, yeni bir yerel enflamasyon biyobelirteci, aterosklerotik plaklar içerisinde makrofajlar tarafından salınırlar. Koroner arter ektazisi (KAE) etyopatogenezisi kesin olarak ortaya konulmamış klinik bir antitedir. ...
Increased serum resistin levels in patients with coronary slow-flow phenomenon
(Urban und Vogel GmbH, 2013)
Background. Slow coronary flow (SCF) is an angiographic finding characterized by delayed opacification of the epicardial coronary arteries without obstructive coronary disease. Resistin, an adipocytokine, plays a major ...
Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI
(Springer Link, 2013)
Background: Macrophages in atherosclerotic plaques secrete YKL-40, a new biomarker of acute and chronic inflammation in patients with stable CAD. We hypothesized that YKL-40 may be a specific marker reflecting the burden ...
